百灵鸟品牌怎么样 申请店铺

我要投票 百灵鸟在中草药行业中的票数:1330 更新时间:2026-01-09
百灵鸟是哪个国家的品牌?「百灵鸟」是 贵州百灵企业集团制药股份有限公司 旗下著名品牌。该品牌发源于贵州,由创始人姜伟在1999期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力百灵鸟品牌出海!将品牌入驻外推网,定制百灵鸟品牌推广信息,可以显著提高百灵鸟产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

百灵鸟怎么样

贵州百灵企业集团于2005年5月组建,现有总资产28亿元。其核心企业(母公司)是贵州百灵企业集团制药股份有限公司(深交所002424),成员包括:贵州百灵企业集团天台山药业有限公司、贵州百灵企业集团医药销售有限公司、贵州百灵企业集团纯净水有限公司、贵州百灵企业集团乾元制药有限公司、贵州百灵企业集团千禧制药有限公司,河北德信润生制药有限公司。
2010年,贵州百灵实现主营业务收入8.67亿元,上缴各项税金1.6亿元,总资产28亿元,员工2100余人。
特色就是品牌内涵,特色就是核心竞争力。贵州百灵立足产品的民族化特色,博采民族医药之众长,以科技创新深度研发为突破,走产业化、规模化的品牌发展道路,现已形成“百灵鸟”牌咳速停糖浆(及胶囊)、银丹心脑通软胶囊、维C银翘片、金感胶囊为主导的强势产品架构,涵盖片剂、胶囊剂、糖浆剂等12种生产剂型,107个药品生产批文,多样化、可持续化的品牌体系日臻完善。贵州百灵的产品经多年医学临床运用,其疗效确切、安全、优质、平价等特点为广大患者、业界、市场广泛认同和赞誉。贵州百灵现已成为国内苗药龙头企业之一。
2010年2月26日,中国证监会发审委审核通过了贵州百灵的上市首发申请,并于6月3日在深圳证券交易所正式挂牌上市。贵州百灵在历经两年半的努力后取得这一重大突破,为贵州百灵借助资本市场的强大动力加快发展奠定了坚实的基础。
用心经营健康、用爱回报社会。多年来,贵州百灵积极履行各项社会责任,为社会各界捐款捐物2000余万元。关注健康、服务社会的企业精神深入人心,集成企业发展的巨大内在动力。
贵州百灵长期致力于宣传贵州,以弘扬民族医药事业为己任,积极寻求企业文化创建的方式和载体,出资赞助贵州百灵围棋队、贵州百灵拉力赛车队、贵州百灵少年围棋队,通过参与多项全国赛事,先后取得全国围棋团体赛冠军、全国汽车拉力锦标赛总冠军等多项殊荣。
壁立千仞造就高贵品质,海纳百川始成大家气象。让特色更特,让优势更优,让深度更深,是贵州百灵追求不断超越的灵魂。面对未来,千帆竞渡百舸争流,在新的竞争平台上贵州百灵清醒地认识自己,不断努力进取、开拓创新,以更加积极向上的姿态向全国民族药主导企业的目标奋力前进。

Guizhou bailing enterprise group was established in May 2005 with total assets of 2.8 billion yuan. Its core enterprise (parent company) is Guizhou bailing Group Pharmaceutical Co., Ltd. (Shenzhen Stock Exchange 002424). Its members include: Guizhou bailing group Tiantaishan Pharmaceutical Co., Ltd., Guizhou bailing Group Pharmaceutical Sales Co., Ltd., Guizhou bailing group pure water Co., Ltd., Guizhou bailing group Qianyuan Pharmaceutical Co., Ltd. and Guizhou bailing group Millennium system Pharmaceutical Co., Ltd., Hebei Dexin Runsheng Pharmaceutical Co., Ltd. In 2010, Guizhou bailing achieved a main business income of 867 million yuan, taxes of 160 million yuan, total assets of 2.8 billion yuan, and more than 2100 employees. Characteristic is the connotation of brand, and characteristic is the core competitiveness. Guizhou bailing, based on the national characteristics of its products, has taken the advantages of national medicine, made a breakthrough in scientific and technological innovation and developed its brand in an industrialized and large-scale way. Now it has formed a strong product structure dominated by "bailingniao" brand keshiding syrup (and capsule), Yindanxinnaotong soft capsule, Weic Yinqiao tablet and Jingan capsule, covering tablet, capsule and syrup With 12 kinds of production dosage forms and 107 drug production approvals, the diversified and sustainable brand system is becoming more and more perfect. Guizhou bailing's products have been used in clinical medicine for many years, and its efficacy is accurate, safe, high-quality, affordable and other characteristics are widely recognized and praised by patients, industry and market. Guizhou bailing has become one of the leading seedling medicine enterprises in China. On February 26, 2010, the development and Audit Committee of CSRC approved the IPO application of Guizhou bailing, and it was officially listed on Shenzhen Stock Exchange on June 3. After two and a half years of efforts, Guizhou bailing has made this major breakthrough, which has laid a solid foundation for Guizhou bailing to speed up its development with the help of the powerful power of the capital market. Manage health with heart and repay society with love. Over the years, Guizhou bailing has actively fulfilled various social responsibilities and donated more than 20 million yuan to all sectors of society. The enterprise spirit of paying attention to health and serving the society is deeply rooted in the people's mind, integrating the huge internal power of enterprise development. Guizhou bailing has been committed to promoting Guizhou for a long time, taking the promotion of national medicine as its own duty, actively seeking the way and carrier of corporate culture creation, funding and sponsoring Guizhou bailing go team, Guizhou bailing Rally Team, Guizhou bailing juvenile go team. Through participating in a number of national events, Guizhou Bailing has successively won the national go team championship, the national automobile rally championship championship and many other titles Honor. The noble quality is created by standing on the wall and embracing all rivers. It is the soul that Guizhou bailing pursues to surpass constantly to make its features more special, advantages better and depth deeper. In the face of the future, Qianfan is competing for the best. On the new competition platform, Guizhou bailing has a clear understanding of itself, and constantly strives to forge ahead, develop and innovate, so as to strive forward to the goal of leading national medicine enterprises with a more positive attitude.

本文链接: https://brand.waitui.com/2d716e852.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

华纳兄弟探索公司拒绝派拉蒙,坚持与Netflix的交易

华纳兄弟探索公司敦促股东拒绝派拉蒙的敌意收购,并重申其将工作室和流媒体资产出售给Netflix的协议是更优报价,且完成路径更明确。(新浪财经)

2小时前

Grok因涉性图像面临审查

埃隆·马斯克麾下未上市企业xAI在其Grok模型被用于生成涉性图像(包括未成年人图像)后受到抨击,这引发了监管机构对该与X平台集成的工具的调查和政策质疑。(新浪财经)

2小时前

保险公司发债规模连续三年超千亿元,多重因素推动

连续三年,保险公司发行债券规模超千亿元。刚刚过去的2025年,23家保险公司发债规模合计达1042亿元。业内人士普遍认为,这背后有多重推动因素——低利率周期下,保险公司普遍面临较高的资本补充需求;利率下行,发债成本更低,险企有动力发新债置换旧债;也有险企希望在利率低位时融资以进一步夯实资本实力、增厚发展安全垫。另外,在逆周期监管思路下,保险公司发债也在一定程度上获得了监管部门的支持。(证券时报)

2小时前

中信建投:白酒板块迎来周期底部配置机会

36氪获悉,中信建投指出,白酒产业“五底阶段”(政策底、库存底、动销底、批价底、产销底)与资本市场“三低一高”(预期低、估值低、公募持仓低、高分红)共振,结合近期市场策略相继落地,站在春节旺季来临之际,认为本轮白酒调整期拐点将至,资本市场预期先行,白酒板块迎来周期底部配置机会。

2小时前

CrowdStrike以7.4亿美元收购身份安全初创公司SGNL

网络安全提供商CrowdStrike周四宣布,将以近7.4亿美元的价格收购身份管理初创公司SGNL,以在人工智能网络攻击时代加强防御。该公司表示,此次收购将帮助CrowdStrike的Falcon云安全平台用户更好地管理人员和人工智能身份访问请求以及实时风险。该交易预计将于2027财年第一季度完成。(新浪财经)

2小时前

本页详细列出关于百灵鸟的品牌信息,含品牌所属公司介绍,百灵鸟所处行业的品牌地位及优势。
咨询